Needham & Company LLC Raises CorMedix (NASDAQ:CRMD) Price Target to $20.00
CorMedix (NASDAQ:CRMD – Get Free Report) had its price objective increased by research analysts at Needham & Company LLC from $15.00 to $20.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s target price would suggest a potential upside of […]
CorMedix (NASDAQ:CRMD – Get Free Report) had its price objective increased by research analysts at Needham & Company LLC from $15.00 to $20.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s target price would suggest a potential upside of […]
